Showing results for stivarga
Refine
x
closemedications | conditions |
FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors
February 25, 2013
The US Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.
FDA approves new treatment for advanced colorectal cancer
September 27, 2012
The US Food and Drug Administration today approved Stivarga (regorafenib) to treat patients with colorectal cancer that has progressed after treatment and spread to other parts of the body (metastatic).